National estimates of HIV-related symptom prevalence from the HIV cost and services utilization study

Medical Care

Volumn 38, Issue 7, 2000, Pages 750-761

  Mathews, Wm Christopher ^a,i   McCutchan, J Allen ^a   Asch, Steven ^d   Turner, Barbara J ^f,g   Gifford, Allen L ^b   Kuromiya, Kiyoshi ^h   Brown, Julie ^e   Shapiro, Martin F ^c,e   Bozzette, Samuel A ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e RAND CORPORATION   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h Critical Path AIDS Project   (United States)

ⁱ UCSD MEDICAL CENTER   (United States)

Author keywords

HIV infection; Prevalence; Survey research; Symptoms

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COST; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PREVALENCE; SOCIOECONOMICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 0034223101     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200007000-00007     Document Type: Article

References (25)

1. Stedman TL. Stedman's medical dictionary. Baltimore, Md: Williams & Wilkins, 1995.
2. Patrick DL, Erickson P. Health status and health policy: Quality of life in health care evaluation and resource allocation. New York, NY: Oxford University Press, 1993:76-77.
3. Mechanic D, Cleary PD, Greenley JR. Distress syndromes, illness behavior, access to care and medical utilization in a defined population. Med Care 1982;20:361-372.
4. Tessler R, Mechanic D, Dimond M. The effect of psychological distress on physician utilization: A prospective study. J Health Soc Behav 1976;17:353-364.
5. Bozzette SA, Berry SH, Duan N, Frankel MR, Leibowitz AA, Lefkowitz D, et al. The care of HIV-infected adults in the United States. N Engl J Med 1998;339:1897-1904.
6. Frankel M, Shapiro M, Duan N, Morton SC, Berry SH, Brown JA, et al. National probability samples in studies of low-prevalence disease, part II: Designing and implementing the HIV Cost and Services Utilization Study Sample. Health Serv Res 1999;34:969-992.
7. Whalen CC, Antani M, Carey J, Landefeld CS. An index of symptoms for infection with human immunodeficiency virus: Reliability and validity. J Clin Epidemiol 1994;47:537-546.
8. Stata statistical software: Release 6.0. College Station, Tex: Stata Corporation, 1999.
9. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
10. Nunnally J. Psychometric theory. New York, NY: McGraw-Hill Book Co, 1978:245.
11. Hamilton L. Regression with graphics. Belmont, Calif: Wadsworth Inc, 1992:109-144.
12. Kaplan RM, Anderson JP, Wu AW. The quality of well-being scale: Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989;27:S27-S43.
13. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994;30A:1326-1336.
14. Brietbart W, Rosenfeld B, Passik S, McDonald MV, Thaler H, Portenoy RK. The undertreatment of pain in ambulatory AIDS patients. Pain 1996;65:243-249.
15. Lubeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus: A community based study. Med Care 1993;31:269-276.
16. Stein MD, Fleishman J, Mor V, Dresser M. Factors associated with patient satisfaction among symptomatic HIV-infected persons. Med Care 1993;31:182-188.
17. Cunningham WE, Bozzette SA, Hays RD, Kanouse DE, Shapiro MF. Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. Med Care 1995;33:AS15-AS25.
18. Revicki DA, Wu AW, Murray MI. Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Med Care 1995;33:AS173-AS182.
19. Bozzette SA, Hays RD, Berry SH, Kanouse DE. A perceived health index for use in persons with advanced HIV disease: Derivation, reliability, and validity. Med Care 1994;32:716-731.
20. Avis NE, Smith K, Mayer K. The relationship among CD4+, hemoglobin, symptoms and quality of life domains in a cohort of HIV-positive men. Int Conf AIDS, July 7-12, 1996. Vol 11.
21. Carr A, Samaras K, Thorisdottir A, Kaufman G, Chisholm D, Cooper D. Diagnosis, prediction and natural course of HTV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. Lancet 1999;353:2093-2099.
22. Mechanic D. The experience and reporting of common physical complaints. J Health Soc Behav 1980;21:146-155.
23. Deyo R, Inui T. Toward clinical applications of health status measures: Sensitivity of scales to clinically important changes. Health Serv Res 1984;19:275-289.
24. Deyo R, Centor R. Assessing the responsiveness of functional scales to clinical change: An analogy to diagnostic test performance. J Chronic Dis 1986;39:897-906.
25. Deyo R, Patrick D. Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care 1989;27:S254-S268.